1-6 of 6
John Mascarenhas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ring Chromosomes in Patients with Myeloid Neoplasms are Associated with a Poor Response to Therapy

Open Access
Subject Area:
Hematology , Oncology
Daniel I. Nathan, Ronald Hoffman, Daiva Ahire, John Mascarenhas, Bridget K. Marcellino, Douglas Tremblay, Lewis R. Silverman, Vesna Najfeld, Jonathan Feld
Journal: Acta Haematologica
Acta Haematol (2025)
https://doi.org/10.1159/000546757
Published Online: 12 June 2025
View articletitled, Ring Chromosomes in Patients with Myeloid Neoplasms are Associated with a Poor Response to Therapy
Open the PDF for Ring Chromosomes in Patients with Myeloid Neoplasms are Associated with a Poor Response to Therapy in another window
Journal Articles

ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera

Available to Purchase
Subject Area:
Hematology , Oncology
John Mascarenhas, Prithviraj Bose, Christopher Hillis, Abdulraheem Yacoub, Firas El Chaer, Dawn Maze, Ghaith Abu-Zeinah, Albert Qin, Victor Priego, Tsewang Tashi, Sonia Cerquozzi, Sunil Babu, Lynda Foltz, Swati Goel, Rupali R. Bhave, Stephanie Lee, Stephen T. Oh, Brandi Reeves, Christopher Benton, Luke Fletcher, Shireen Sirhan, Hana Safah, Hayman Salib, Pierre J.A. Villeneuve, Oleh Zagrijtschuk, Henry Castro, Lucia Masarova
Journal: Acta Haematologica
Acta Haematol (2025)
https://doi.org/10.1159/000544818
Published Online: 05 March 2025
View articletitled, ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera
Open the PDF for ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera in another window
Journal Articles

Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022

Available to Purchase
Subject Area:
Hematology , Oncology
Dahniel Sastow, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya, John Mascarenhas, Douglas Tremblay
Journal: Acta Haematologica
Acta Haematol (2024) 147 (3): 292–299.
https://doi.org/10.1159/000533819
Published Online: 26 September 2023
View articletitled, Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022
Open the PDF for Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022 in another window
Journal Articles

The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis

Available to Purchase
Subject Area:
Hematology , Oncology
Leonard Naymagon, Douglas Tremblay, John Mascarenhas
Journal: Acta Haematologica
Acta Haematol (2021) 144 (5): 560–568.
https://doi.org/10.1159/000514920
Published Online: 07 April 2021
View articletitled, The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis
Open the PDF for The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis in another window
Journal Articles

Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms

Available to Purchase
Subject Area:
Hematology , Oncology
Selena Zhou, Douglas Tremblay, Ronald Hoffman, Marina Kremyanskaya, Vesna Najfeld, Lihua Li, Erin Moshier, John Mascarenhas
Journal: Acta Haematologica
Acta Haematol (2021) 144 (1): 48–57.
https://doi.org/10.1159/000506146
Published Online: 11 March 2020
View articletitled, Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms
Open the PDF for Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms in another window
Journal Articles

A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature

Available to Purchase
Subject Area:
Hematology , Oncology
Hannah Levavi, Joseph Tripodi, Bridget Marcellino, John Mascarenhas, Amy V. Jones, Nicholas C.P. Cross, Diana Gruenstein, Vesna Najfeld
Journal: Acta Haematologica
Acta Haematol (2019) 142 (2): 105–112.
https://doi.org/10.1159/000498945
Published Online: 08 August 2019
View articletitled, A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature
Open the PDF for A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature in another window